Premium
TetraLogic Pharmaceuticals Corporation (CE) (TLOG)
USOTC
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
PAOLI, Pa., Nov. 02, 2016 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) (“TetraLogic” or “Company”), a clinical-stage biopharmaceutical company focused on...
Biotechnology Stocks on our Radar -- Array BioPharma, PDL BioPharma, Advaxis, and TetraLogic Pharma PR Newswire NEW YORK, June 16, 2016 NEW YORK, June 16, 2016 /PRNewswire/ -- On Wednesday, June...
Birinapant Shows No Activity in Randomized Phase 2 MDS Study SHAPE Shows Clinical Benefit in Randomized Phase 2 CTCL Study MALVERN, Pa., Jan. 06, 2016 (GLOBE NEWSWIRE) -- TetraLogic...
MALVERN, Pa., Nov. 9, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that two abstracts discussing clinical data on birinapant will be presented at...
MALVERN, Pa., Nov. 4, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
MALVERN, Pa., Nov. 2, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it has an open U.S. Investigational New Drug application in support of a...
Updates on MDS Clinical Program - Free Research Report on TetraLogic Pharmaceuticals Corporation PR Newswire NEW YORK, July 15, 2015 NEW YORK, July 15, 2015 /PRNewswire/ -- ACI Association has...
MALVERN, Pa., May 6, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
MALVERN, Pa., May 6, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
MALVERN, Pa., May 1, 2015 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG), a clinical-stage biopharmaceutical company focused on discovering and developing novel small...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 29841 | 1.28E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 21378 | 1.23E-6 | CS |
| 52 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 13405 | 1.23E-6 | CS |
| 156 | -0.004999 | -99.98 | 0.005 | 0.006 | 1.0E-6 | 11095 | 0.00169456 | CS |
| 260 | -0.037519 | -99.9973347548 | 0.03752 | 0.06 | 1.0E-6 | 31339 | 0.02028732 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
